Phase 2 Staphylococcus Aureus Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
AstraZeneca231 enrolled42 locationsNCT06749457
Recruiting
Phase 2
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+1 more
Todd C. Lee MD MPH FIDSA60 enrolled5 locationsNCT04886284
Recruiting
Phase 2
Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection
Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
University Hospital, Basel, Switzerland36 enrolled1 locationNCT05655091
Completed
Phase 2
A Randomised, Double-Blind, Vehicle-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Two Dosage Forms of BTX 1801 Applied Twice Daily for Five Days to the Anterior Nares of Healthy Adults Nasally Colonised with Staphylococcus aureus
Staphylococcus aureus infection
Botanix Pharmaceuticals Ltd60 enrolled1 locationACTRN12620000456954
Recruiting
Phase 2
Intranasal white petrolatum versus chlorhexidine to reduce postoperative infections in dermatologic surgery
Incidence of postoperative wound infectionsPrevalance of staphylococcus aureus carriageSkin Cancer
Eugene Tan2,000 enrolled1 locationACTRN12612001051831
Completed
Phase 2
CAMERA - Combination Antibiotic treatment for Methicillin Resistant Staphylococcus Aureus
Methicillin Resistant Staphylococcus Aureus Bacteraemia
Dr Joshua Davis60 enrolled1 locationACTRN12610000940077
Completed
Phase 2
A Phase 1/2, Single-Center, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in the Reduction or Eradication of Staphylococcus aureus Nasal Carriage among Adults
Stable nasal carriage of Staphylococcus aureus in adults
Neosil, Inc.36 enrolled1 locationACTRN12607000267459